U.K. Health Officials Call for Banning Schoolchildren Without Proof of MMR Vaccination
Health officials in London, England are calling for children who have not received MMR (measles, mumps, rubella) shots to be banned from attending schools in the United Kingdom as measles cases continue to rise. Emma Best, chairwoman of the London Assembly Health Committee, said students who can’t show proof they have gotten the MMR vaccine […]
Nursing Home Residents Routinely Given Vaccines Rarely Represented in Clinical Trials
According to researchers at the University of Aberdeen in Scotland, people living in older care homes have been largely excluded from vaccine trials, despite being among the groups most likely to receive vaccines, especially during public health emergencies. Researchers say this mismatch has limited the evidence available on how vaccines perform in care nursing home […]
U.K. School Lockdowns Return Amid “Super Flu” Surge Reports
A “super-flu” strain is being reported across the United Kingdom, prompting several schools to close and increasing admissions to hospitals as influenza infection rates rise.1 The outbreak involves a mutation of the influenza A virus known as either H3N2 or as subclade K, emerging earlier in the winter than usual and contributing to disruption across […]
U.K Council Wins Case to Vaccinate Baby Despite Mother’s Objection
A High Court judge has ruled that Islington Council in North London, United Kingdom may proceed with routine childhood vaccinations for an eight-month-old baby girl despite the strong objections of her mother, who argued the vaccines posed health risk for her child. The child, referred to in court documents only as P, has been under […]
Fast-Tracked DNA-Based Therapeutic Cancer Vaccine to Be Given to Melanoma Patients in U.K.
Patients in England with advanced skin melanoma are receiving a “revolutionary” new therapeutic cancer vaccine in a National Health Service (NHS) clinical trial that is being used to fast-track the biological to licensure. The vaccine, iSCIB1+—also known as ImmunoBody—is a DNA-based treatment designed to boost the immune system’s ability to target and remember melanoma cells.1 […]
Novel Breast Cancer Vaccine Technology Receives Japanese Patent
Anixa Biosciences, Inc. of San Jose, California announced on July 17, 2024, that its collaborator, the Cleveland Clinic, has received a “Decision to Grant” notice from the Japan Patent Office (JPO) for the patent application titled “Vaccine Adjuvants and Formulations” for its novel breast cancer vaccine technology. The company is two decades into developing a […]